| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/04/2011 | US20110191904 Plant Genes Associated With Seed Oil Content And Methods Of Their Use |
| 08/04/2011 | US20110191903 Engineering plant resistance to diseases caused by pathogens |
| 08/04/2011 | US20110191902 Methods and Compositions for Increasing Storage-Life of Fruit |
| 08/04/2011 | US20110191901 Methods for breeding glyphosate resistant plants and compositions thereof |
| 08/04/2011 | US20110191900 Cry1f and cry1ac transgenic cotton lines and event-specific identification thereof |
| 08/04/2011 | US20110191898 Compositions and Methods for Enhanced Amino Acid Levels in Plants |
| 08/04/2011 | US20110191897 Plants Tolerant to HPPD Inhibitor Herbicides |
| 08/04/2011 | US20110191896 Methods and compositions for increasing plant disease resistance and yield |
| 08/04/2011 | US20110191895 Plant farnesyltransferases |
| 08/04/2011 | US20110191894 Methods and compositions relating to conrolled induction of plant senescence |
| 08/04/2011 | US20110191891 Garden Bean Cultivar H37111 |
| 08/04/2011 | US20110191879 Soybean Cultivar 3317361 |
| 08/04/2011 | US20110191878 Msca1 nucleotide sequences impacting plant male fertility and method of using same |
| 08/04/2011 | US20110191876 Glyphosate tolerant perennial ryegrass named 'jacklin 501' |
| 08/04/2011 | US20110191875 Compositions and methods for making androstenediones |
| 08/04/2011 | US20110191874 Compositions and methods for detecting and modulating cell death by a translation regulated gene expression system |
| 08/04/2011 | US20110191873 Methods of Protein Destabilization and Uses Thereof |
| 08/04/2011 | US20110191870 I-crei homing endonuclease variants having novel cleavage specificity and use therof |
| 08/04/2011 | US20110191866 Methods of making monoclonal antibodies using fusion-peptide epitope adoptive transfer (f-peat) technology |
| 08/04/2011 | US20110190730 Methods of inducing pluripotency involving oct4 protein |
| 08/04/2011 | US20110190729 Methods of inducing pluripotency involving sox2 protein |
| 08/04/2011 | US20110190484 Nucleic acid molecule |
| 08/04/2011 | US20110190445 Inhibition of hrp-3 using modified oligonucleotides |
| 08/04/2011 | US20110190386 Aptamer Inhibitors of Osteopontin and Methods of Use Thereof |
| 08/04/2011 | US20110190385 Methods and Products for Reawakening Retrocyclins |
| 08/04/2011 | US20110190384 siRNA Specific to WT1 17AA(-)Isoform and Use Thereof |
| 08/04/2011 | US20110190382 Treatment of Cancer by Inhibition of IGFBPs and Clusterin |
| 08/04/2011 | US20110190381 Rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma |
| 08/04/2011 | US20110190378 Mir 204, mir 211, their anti-mirs, and therapeutic uses of same |
| 08/04/2011 | US20110190377 Method for producing a cell and/or tissue and/or disease phase specific medicament |
| 08/04/2011 | US20110190376 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA |
| 08/04/2011 | US20110190375 Compositions comprising cmyc sirna and methods of use thereof |
| 08/04/2011 | US20110190371 Genetic suppression and replacement |
| 08/04/2011 | US20110190370 Modulation of hif1(alpha) and hif2(alpha) expression |
| 08/04/2011 | US20110190224 Non-Viral Delivery of Compounds to Mitochondria |
| 08/04/2011 | US20110190223 Hemcm42 nucleic acids |
| 08/04/2011 | US20110190218 Bag-1 peptide that inhibits prostate cancer |
| 08/04/2011 | US20110190168 Apoptosis modulator bcl-b and methods for making and using same |
| 08/04/2011 | US20110190164 Chimeric fusion proteins and virus like particles from birnavirus vp2 |
| 08/04/2011 | US20110190159 Multi-chain eukaryotic display vectors and uses thereof |
| 08/04/2011 | US20110190154 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 08/04/2011 | US20110190152 Pluripotency associated epigenetic factor |
| 08/04/2011 | US20110190144 Novel compositions and methods for the treatment of psoriasis |
| 08/04/2011 | US20110190141 Evolving New Molecular Function |
| 08/04/2011 | US20110190140 Evolution of whole cells and organisms by recursive sequence recombination |
| 08/04/2011 | US20110189776 PROKARYOTIC RNAi-LIKE SYSTEM AND METHODS OF USE |
| 08/04/2011 | US20110189775 Targeted genomic alteration |
| 08/04/2011 | US20110189766 Micrornas and uses thereof |
| 08/04/2011 | US20110189758 Transfection vector |
| 08/04/2011 | US20110189757 Transfection vector |
| 08/04/2011 | US20110189737 Methods for producing hyaluronan in a recombinant host cell |
| 08/04/2011 | US20110189734 Novel methods and cell lines |
| 08/04/2011 | US20110189731 Polynucleotides encoding recombinant lubricin molecules and uses thereof |
| 08/04/2011 | US20110189730 Viral nucleocapsid protein as a multifunctional translation initiation factor and increased protein and polypeptide production using same |
| 08/04/2011 | US20110189729 Novel recombination sequences |
| 08/04/2011 | US20110189717 Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway |
| 08/04/2011 | US20110189711 Paad domain-containing polypeptides, encoding nucleic acids, and methods of use |
| 08/04/2011 | US20110189696 Monoclonal antibody stro-4 |
| 08/04/2011 | US20110189689 Riboswitches |
| 08/04/2011 | US20110189684 Method for determining drug resistance mutations in any of the non-structural protein regions ns3 to ns5b of hepatitis c virus (hcv) for genotypes 1 to 6 |
| 08/04/2011 | US20110189339 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation |
| 08/04/2011 | US20110189300 siRNA SILENCING OF APOLIPOPROTEIN B |
| 08/04/2011 | US20110189267 MULTIPLE CpG OLIGODEOXYNUCLEOTIDE AND THEIR USE TO INDUCE AN IMMUNE RESPONSE |
| 08/04/2011 | US20110189264 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
| 08/04/2011 | US20110189234 Adenovirus particles having a chimeric adenovirus spike protein, use thereof and methods for producing such particles |
| 08/04/2011 | US20110189233 Recombinant Varicella-Zoster Virus |
| 08/04/2011 | US20110189232 RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1 |
| 08/04/2011 | US20110189225 Attenuated bacteria useful in vaccines |
| 08/04/2011 | US20110189224 Pestivirus replicons providing an rna-based viral vector system |
| 08/04/2011 | US20110189218 Plasmodium vivax hybrid circumsporozoite protein and vaccine |
| 08/04/2011 | US20110189207 Methods for soluble zalpha11 cytokine receptors |
| 08/04/2011 | US20110189206 Antibody Targeting Through a Modular Recognition Domain |
| 08/04/2011 | US20110189199 Methods for p2ry5 mediated regulation of hair growth and mutants thereof |
| 08/04/2011 | US20110189196 Metal-citrate transporter antigen from streptomyces coelicolor and uses thereof |
| 08/04/2011 | US20110189195 Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl trna synthetase |
| 08/04/2011 | US20110189190 Anti-hepcidin-25 selective antibodies and uses thereof |
| 08/04/2011 | US20110189187 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/04/2011 | US20110189183 Antibodies against candida, collections thereof and methods of use |
| 08/04/2011 | US20110189182 Proteolytically cleavable fusion proteins with high molar specific activity |
| 08/04/2011 | US20110189180 Antigenic compositions and use of same in the targeted delivery of nucleic acids |
| 08/04/2011 | US20110189179 Identification of Tumor-Associated Antigens for Diagnosis and Therapy |
| 08/04/2011 | US20110189177 Antibodies to vla-1 |
| 08/04/2011 | US20110189168 Antibody-induced apoptosis |
| 08/04/2011 | US20110189164 Peptide Stabilizer Compounds and Screening Method |
| 08/04/2011 | US20110189162 Modified Clostridial Toxins Comprising an Integrated Protease Cleavage Site-Binding Domain |
| 08/04/2011 | US20110189159 Methods and compositions for protein delivery |
| 08/04/2011 | US20110189158 Clostridial neurotoxins with altered persistency |
| 08/04/2011 | US20110189155 Large Form Of Human 2',5'-Oligoadenylate Synthetase OAS3 for Preventing or Treating Infection With Positive-Sense Single-Stranded RNA Viruses |
| 08/04/2011 | US20110189154 Applications For A New Class Of Enzymes: Sulfiredoxins |
| 08/04/2011 | US20110189142 Senescene Cells and Methods For Its Production |
| 08/04/2011 | US20110189141 Multiple target t cell receptor |
| 08/04/2011 | US20110189139 Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 Polypeptide |
| 08/04/2011 | US20110189137 Method for generation and regulation of ips cells and compositions thereof |
| 08/04/2011 | US20110189128 Recombinant super-compound interferon |
| 08/04/2011 | US20110189124 Methods for refolding proteins containing free cysteine residues |
| 08/04/2011 | US20110189123 Mammalian cx3c chemokine antibodies |
| 08/04/2011 | US20110189120 Aegyptin and uses thereof |
| 08/04/2011 | US20110189105 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 08/04/2011 | US20110189082 Human gm-csf antigen binding proteins |
| 08/04/2011 | US20110186524 Porous Ferro- or Ferrimagnetic Glass Particles for Isolating Molecules |